Skip to content
lifestyle.tvshowauditions.info
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aspire Biopharma Holdings, Inc.
Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors
February 13, 2026
Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))
February 12, 2026
Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements
February 12, 2026
Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 11, 2026
←
Previous Page
1
2
3